Affiliations: [a] Ludwig Boltzmann Institute for Rehabilitation of Internal Diseases, Saalfelden, Austria | [b] Rehabilitation Centre for Rheumatic Diseases, PVA Saalfelden, Austria
Correspondence:
[*]
Address for correspondence: Univ.-Doz. Dr. W. Kullich, Ludwig Boltzmann Institute for Rehabilitation of Internal Diseases, Thorerstraße 26, A-5760 Saalfelden, Austria. Tel.: +43 6582 790 71180; Fax: +43 6582 790 71290; E-mail: [email protected]
Abstract: A new treatment system using nuclear resonance as its active principle was applied, as an adjunct to a normal standardized physiotherapy programme. This novel NuclearResonanceTherapy (MBST® or MBS-Therapy) was applied for one hour on five successive days. The study was performed double blind, placebo-controlled and randomised on 62 rehabilitation patients suffering from chronic Low Back Pain at baseline, after one week and after 3 months. The pain measurements using the Visual Analogue Scale (VAS) showed a distinct reduction of pain after active MBST® and placebo. The Roland & Morris Disability Index (RM) total score also improved significantly in both groups, but the improvement was more distinct in MBST® patients compared to placebo. After three months, the positive effect of MBST® on the RM total score was still significant (p<0.00001) whereas this was not the case for the placebo-treatment. The significant improvement in the MBST®-group was primarily evident in the RM-questions regarding incapacities caused by Low Back Pain, particularly sleeping problems, fatigue, bending ability, and the time required to get dressed. NuclearResonanceTherapy as a complementary treatment can improve the outcome obtained by inpatient rehabilitation programmes after 3 months.
Keywords: NuclearResonanceTherapy, MBST®, chronic low back pain, rehabilitation, Roland & Morris disability index
